C-Myc inhibitor 6
C-Myc inhibitor 6 (compound A102) is a c-Myc inhibitor. c-Myc inhibitor 6 decreases cancer cell viability and degrades c-Myc protein. c-Myc inhibitor 6 can be used for the research of c-Myc imbalance, such as cancer, cardiovascular diseases, and viral infection[1].
Product Specifications
CAS Number
[2768765-58-6]
UNSPSC
12352005
Target
C-Myc
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/c-myc-inhibitor-6.html
Purity
98.04
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)C[C@@H](B(O)O)NC(CCNC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)=O
Molecular Formula
C23H29BN2O5
Molecular Weight
424.30
References & Citations
[1]Tong, Youzhi, et al. C-myc protein inhibitor, preparation method therefor, and use thereof. WO2022089556. 2021.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Helicobacter hepaticus Pyridoxine 5'-phosphate synthase (pdxJ)
Recombinant Helicobacter hepaticus Pyridoxine 5'-phosphate synthase (pdxJ)
Recombinant Helicobacter hepaticus Pyridoxine 5'-phosphate synthase (pdxJ)
Recombinant Helicobacter hepaticus Pyridoxine 5'-phosphate synthase (pdxJ)